DHEA was observed to diminish the detection of NADPH (Fig
DHEA was observed to diminish the detection of NADPH (Fig. from a PKG knockin mouse made up of a serine in place of a cysteine involved in PKG dimerization. DHEA promoted increased PKG dimerization in lungs from wild-type mice, which was not detected in the PKG knockin mouse model. Thus PKG-1 dimerization is usually a major contributing factor to the vasodilator actions of DHEA and perhaps its beneficial effects in treating pulmonary hypertension. Keywords:cGMP, glucose-6-phosphate dehydrogenase, pulmonary hypertension early studiesby Archer and Weir around the mechanism of hypoxic pulmonary vasoconstriction suggested that this oxidation of cytosolic NAD(P)H promoted vasorelaxation of pulmonary arterial easy muscle by opening potassium channels (3,27). Observations that inhibitors of glucose-6-phosphate dehydrogenase (G6PD) promote vascular relaxation through mechanisms including opening numerous potassium channels (10,16) developed into evidence for Clonidine hydrochloride cytosolic NADPH oxidation being a coordinator of mechanisms mediating vascular relaxation (13,17,25). Recent studies from our laboratory in bovine pulmonary arteries (BPA) suggested that cytosolic NADPH oxidation resulting from inhibition of G6PD by 6-aminonicotinamide promotes relaxation through activation of protein kinase G 1 (PKG-1) by a thiol oxidation-mediated subunit dimerization (25). Vascular relaxation through this cGMP-independent mechanism of PKG activation by dimerization was initially reported by the Eaton laboratory to function as a novel and major contributing mechanism to the relaxation of systemic arteries to peroxide (5). Earlier studies from our laboratory provided evidence that hydrogen peroxide (H2O2) stimulates soluble guanylate cyclase (sGC) under conditions where it relaxes isolated endothelium-removed BPA (7). Subsequently, our laboratory documented evidence that peroxide appears to unwind BPA by both a sGC/cGMP-dependent and a dimerization-dependent activation of PKG and that decreases in both of these mechanisms appear to contribute to the contraction of BPA elicited by acute hypoxia (23,24). It is now known that this oxidation of cytosolic NADPH appears to both activate and coordinate multiple relaxing mechanisms in pulmonary and systemic arteries across several animal species (13,14,16,17,25). Thus cGMP-independent activation of PKG dimerization may be a major factor in the coordination of multiple processes contributing to vascular relaxation resulting from cytosolic NADPH oxidation. Dehydroepiandrosterone (DHEA) is usually a steroid hormone that protects animals from your development of pulmonary hypertension, and it Clonidine hydrochloride is currently being investigated in clinical trials for the treatment of patients with pulmonary hypertension (2,4,9,18,20,26). Although it is known that Clonidine hydrochloride DHEA functions as an inhibitor of G6PD (16,31), it has also been suggested to promote vasodilation through several different mechanisms including opening voltage-regulated potassium and/or calcium channels (10,16), upregulating sGC (26), and by decreasing Rho kinase activity (20). In this study, we used a redox-dead PKG knockin (PKG-KI, 28) mouse model to provide novel evidence that could define the role of PKG dimerization in the vasodilator actions of DHEA. This mouse model was generated by the Eaton laboratory based on the properties of PKG dimerization (5,28). In this mouse model, cysteine that is involved in PKG dimerization by peroxide is Clonidine hydrochloride usually replaced by serine, preventing both dimerization and PKG activation. Thus, if DHEA promoted relaxation through PKG activation by dimerization, its vasodilator actions should be attenuated along with effects of peroxide in arteries from this mouse model. In addition, we also examined the effects of DHEA on PKG dimerization and activation in BPA under both aerobic and hypoxic conditions to determine whether PKG dimerization is usually a major factor in the actions of DHEA. Based on Itga5 our previous studies with the G6PD inhibitor 6-aminonicotinamide, we hypothesized that DHEA may promote a PKG dimerization-mediated relaxation.